eptacog alfa activated recombinant dna coagulation factor vii

Italy

Drugs containing this active substance

  • NOVOSEVEN

    NovoSeven is a coagulation factor used to treat bleeding and prevent excessive bleeding after surgery or other major treatments. It is indicated for people with hemophilia (congenital or acquired), Factor VII deficiency, Glanzmann thrombasthenia, or to treat severe postpartum hemorrhage.

    Form: solution for injection, powder and solvent

    Active substance Dosage
    eptacog alfa activated recombinant dna coagulation factor vii -

    ATC: B02BD08

    Manufacturer: NOVO NORDISK A/S